Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Verruca vulgaris

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    7 result(s) found for: Verruca vulgaris. Displaying page 1 of 1.
    EudraCT Number: 2007-006738-33 Sponsor Protocol Number: CL-1205 Start Date*: 2008-03-14
    Sponsor Name:NatImmune A/S
    Full Title: bLAC - A phase II double-blind, placebo controlled, clinical proof of concept trial of the efficacy of 8 weeks treatment of cutaneous warts with bLAC in immune suppressed, kidney transplanted patients
    Medical condition: Cutaneous wart lesions on hands and/or feet at immune suppressed, kidney transplanted patients.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010115 Common warts LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-012210-48 Sponsor Protocol Number: 20407 Start Date*: 2009-08-06
    Sponsor Name:Leiden University Medical Centre
    Full Title: Monochloroacetic acid versus cryotherapy in the treatment of warts: A Randomised Clinical Trial (WARTS-2)
    Medical condition: All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type vulgaris on hands or feet.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010115 Common warts LLT
    9.1 10035158 Plantar warts LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016302-16 Sponsor Protocol Number: DPSI-IDP-109-P2-01 Start Date*: 2010-03-19
    Sponsor Name:Dow Pharmaceutical Sciences Inc.
    Full Title: A Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of IDP-109 Solution in the Treatment of Patients with Verrucae Vulgares
    Medical condition: Verrucae vulgares
    Disease: Version SOC Term Classification Code Term Level
    12.1 10010115 Common warts LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-003688-39 Sponsor Protocol Number: CLS003-CO-PR-002 Start Date*: 2014-11-26
    Sponsor Name:Cutanea Life Sciences
    Full Title: A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Proof-of-Concept Study to Evaluate Efficacy and Safety of Topical Ionic Contra-viral Therapy (ICVT) Comprised of Digoxin and Furosemide in C...
    Medical condition: Patients with at least two warts who are otherwise healthy subjects
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004864 10010115 Common warts LLT
    17.1 100000004864 10035158 Plantar warts LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004044-36 Sponsor Protocol Number: 2008-213 Start Date*: 2008-09-02
    Sponsor Name:Bispebjerg Hospital
    Full Title: Behandling af præmaligne hudlæsioner med topikal imiquimod og fotodynamisk terapi hos organtransplanterede patienter - et randomiseret intraindividuelt forsøg med blindet effektvurdering
    Medical condition: Aktiniske keratoser og virale vorter
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000614 Actinic keratosis LLT
    9.1 10047829 Warts (viral) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006863-35 Sponsor Protocol Number: 314759 Start Date*: 2013-10-01
    Sponsor Name:Bispebjerg Hospital
    Full Title: Prophylactic photodynamic therapy for organ transplant patients – a randomised, intra-individual trial with blinded outcome evaluation.
    Medical condition: Development of actinic keratoses and skin cancer in kidney transplant patients - a randomised, intra-individual trial with blinded outcome evaluation.
    Disease: Version SOC Term Classification Code Term Level
    16.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10040808 Skin cancer PT
    16.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10047829 Warts (viral) LLT
    16.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001443-52 Sponsor Protocol Number: LLB-2019-02 Start Date*: 2019-11-13
    Sponsor Name:LABO'LIFE Belgium sprl
    Full Title: Randomized study to evaluate 2LVERU® JUNIOR and 2LVERU® efficacy on the treatment of warts. Protocol EVAsION
    Medical condition: Non genital warts infection
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10035150 Planar warts LLT
    20.0 100000004864 10035158 Plantar warts LLT
    20.0 100000004864 10047828 Warts LLT
    21.1 100000004864 10010115 Common warts LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Trial now transitioned)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 19 12:01:59 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA